STLNW 8-K 2026-11-05

Starling Oncology, Inc. (STLNW) 8-K dated 2026-11-05 — accession 0001079973-26-001430.

Starling Oncology, Inc. (STLNW) warrant.

TOIIW: FOR IMMEDIATE RELEASE

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Income-statement cache for STLNW is thin on this filing URL. We will not invent exhibit numbers.

Not investment advice. The STLNW SEC hub lists recent forms. The stock page is the research view.